368 related articles for article (PubMed ID: 15349109)
1. AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.
Haigh PI; Urbach DR; Rotstein LE
Surgery; 2004 Sep; 136(3):609-16. PubMed ID: 15349109
[TBL] [Abstract][Full Text] [Related]
2. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer.
Haigh PI; Urbach DR; Rotstein LE
Ann Surg Oncol; 2005 Jan; 12(1):81-9. PubMed ID: 15827782
[TBL] [Abstract][Full Text] [Related]
3. Selective surgery and adjuvant therapy based on risk classifications of well-differentiated thyroid cancer.
Cross S; Wei JP; Kim S; Brams DM
J Surg Oncol; 2006 Dec; 94(8):678-82. PubMed ID: 17131414
[TBL] [Abstract][Full Text] [Related]
4. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of AMES scoring system in selection of extent of surgery in well differentiated carcinoma of thyroid.
Van Nguyen K; Dilawari RA
Am Surg; 1995 Feb; 61(2):151-5. PubMed ID: 7856976
[TBL] [Abstract][Full Text] [Related]
6. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
[TBL] [Abstract][Full Text] [Related]
7. Importance of lymph node metastases in follicular thyroid cancer.
Witte J; Goretzki PE; Dieken J; Simon D; Röher HD
World J Surg; 2002 Aug; 26(8):1017-22. PubMed ID: 12045860
[TBL] [Abstract][Full Text] [Related]
8. Predicting outcome and directing therapy for papillary thyroid carcinoma.
Kim S; Wei JP; Braveman JM; Brams DM
Arch Surg; 2004 Apr; 139(4):390-4; discussion 393-4. PubMed ID: 15078706
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.
Machens A; Holzhausen HJ; Lautenschläger C; Thanh PN; Dralle H
Cancer; 2003 Aug; 98(4):712-9. PubMed ID: 12910514
[TBL] [Abstract][Full Text] [Related]
10. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
11. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma.
Marchesi M; Biffoni M; Biancari F; Berni A; Campana FP
Eur J Surg Suppl; 2003 Jul; (588):46-50. PubMed ID: 15200043
[TBL] [Abstract][Full Text] [Related]
12. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
Yildirim E
J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
Włoch J; Czarniecka A; Turska M; Wilgus J
Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
[TBL] [Abstract][Full Text] [Related]
14. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
Liu WS; Qi YF; Tang PZ
Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
[TBL] [Abstract][Full Text] [Related]
15. [Differentiated thyroid carcinoma: prognostic factors].
Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
[TBL] [Abstract][Full Text] [Related]
16. Treatment of thyroid cancer based on risk groups.
Shaha A
J Surg Oncol; 2006 Dec; 94(8):683-91. PubMed ID: 17131422
[TBL] [Abstract][Full Text] [Related]
17. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients with differentiated thyroid carcinoma.
Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
[TBL] [Abstract][Full Text] [Related]
19. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
20. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart.
Haigh PI; Urbach DR
Surgery; 2005 Dec; 138(6):1152-7; discussion 1157-8. PubMed ID: 16360403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
